Rezolute (RZLT) Other Non Operating Income (2014 - 2025)
Rezolute (RZLT) posted Other Non Operating Income of -$15000.0 for Q3 2025, down 150.0% sequentially from -$6000.0 in Q1 2025, and little changed YoY from -$15000.0 in Q3 2024.
Powered by 
Analysis
Rezolute (RZLT) Other Non Operating Income (2014 - 2025) Analysis & Trends
Rezolute has reported Other Non Operating Income for 11 years, with the latest figure at -$15000.0 in Q3 2025.
- Quarterly Other Non Operating Income changed 0.0% year-over-year to -$15000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was -$21000.0 (up 97.7% YoY) and the FY2024 annual result came in at -$2.8 million, down 56900.0% from the prior year.
- Other Non Operating Income eased to -$15000.0 in Q3 2025 per RZLT's latest filing, from -$6000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.8 million in Q1 2021 and troughed at -$2.0 million in Q1 2024.
- A 5-year average of -$161555.6 and a median of -$13000.0 in 2022 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income plunged 35360.0% in 2022, then surged 133.33% in 2024.
- Over 5 years, Other Non Operating Income stood at -$12000.0 in 2021, then fell by 8.33% to -$13000.0 in 2022, then slumped by 38.46% to -$18000.0 in 2023, then soared by 133.33% to $6000.0 in 2024, then plunged by 350.0% to -$15000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$15000.0, -$6000.0, and $6000.0 for Q3 2025, Q1 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Rezolute | 478.07 Mn | 478.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -15,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -900,000.00 |
| Mar 31, 2024 | -1.96 Mn |
| Dec 31, 2023 | -18,000.00 |
| Sep 30, 2023 | -14,000.00 |
| Jun 30, 2023 | 35,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -13,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | 6.55 Mn |
| Mar 31, 2022 | -12,000.00 |
| Dec 31, 2021 | -12,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 1.78 Mn |
| Jun 30, 2019 | 96.00 |
| Dec 31, 2018 | 55,000.00 |